ORNL scientists introduce a biosensor for real-time RNA monitoring in plants, promising advancements in agriculture and ...

Drug developers will now have enhanced abilities to rapidly prototype, test, iterate, and scale up their mRNA therapeutics.

ORNL scientists created a biosensor technology that lets researchers visualize and track RNA activity in living plants, using ...

Scientists at Oak Ridge National Laboratory have developed the first-ever method of detecting ribonucleic acid, or RNA, ...

ORNL scientists created a biosensor technology that lets researchers visualize and track RNA activity in living plants, using ...

Circio and Entos have initiated a research collaboration that will involve joint development and in vivo delivery testing of ...

Ovarian cancer, a leading cause of death among gynecological malignancies, has a poor prognosis and low 5-year survival rate, ...

The results of a study that identified the pathological mechanism of spinal stenosis and the target gene for treatment ...

The study is useful for advancing spatial transcriptomics through its novel regression-based linear model (glmSMA) that integrates single-cell RNA-seq with spatial reference atlases, though its ...

Binding of miR-3036-5p to CYP18A1 can be prevented by an A-to-I RNA editing, thus elevating CYP18A1 expression, decreasing 20E titer, and finally regulating the wing dimorphism of offspring in aphid.

Stoke Therapeutics, Inc. is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine and has a lead investigational medicine, zorevunersen ...

There is an urgent need for precision immunotherapy strategies that simultaneously target both tumor cells and immune cells ...